Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment

Clinical trial NCT06664138 · COMPLETED

Trial details

NCT number: NCT06664138
Sponsor: Yeongseok Yun
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophenia Disorder Major Depression Disorders Schizoaffective Disorder Bipolar

Start date: 2023-04-28
Primary completion: 2024-01-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.